For your next procedure visit: start with selection, timing, and the record below. For planning a service: jump to the team workflow, costs, and the dated policy proposal.
Start with the patient and setting
An office procedure creates work before and after the intervention: selecting the patient, preparing the room, explaining the choice, documenting what happened, and following the result. Plan that episode before deciding how to fit it into the schedule.
Before opening the tray, establish the indication, alternatives, patient preference, urgency, and any factors that change risk. Then ask whether your training, staffing, equipment, and ability to manage complications fit this patient and procedure. Referral is appropriate when those needs exceed the office's capabilities.
Use the procedure's current guidance and institutional standards for indications, contraindications, consent, and technique. Include a review of medicines and relevant interactions in preparation.
A skin lesion needs diagnosis
A patient asks to have a changing lesion removed. The first decision is the appropriate evaluation and diagnostic approach. Destruction treats tissue without preserving a diagnostic specimen; biopsy provides tissue for pathology. Choose the method from the suspected diagnosis and the information needed.
Plan the whole episode: choose the appropriate procedure or referral, obtain consent, arrange specimen handling if tissue is sampled, give aftercare instructions, and identify who will communicate pathology and arrange any further treatment.
Choose today or a dedicated visit
Same-day care can spare the patient another trip and reduce delays. A dedicated appointment can provide the preparation, time, assistance, analgesia, or equipment needed for safe care.
| Consider same-day care when | Consider a dedicated visit or referral when |
|---|---|
| The indication is established and the patient wants to proceed. | Further evaluation or a decision discussion is needed before proceeding. |
| Required staff, supplies, medication/device, and safety checks are available. | Preparation, trained assistance, equipment, or coverage arrangements are incomplete. |
| There is enough time for the procedure and other necessary care. | Performing it now would rush consent, technique, aftercare, or another important assessment. |
| Delaying would create avoidable burden or interfere with timely care. | A different setting is safer or the patient prefers a separate appointment. |
Procedure duration varies with the patient, technique, clinician experience, and assistance. Measure your own room and staff time. A five-minute injection can require substantially more total visit capacity after preparation, consent, and aftercare.
A patient requests an IUD today
The patient wants an intrauterine device, is clinically eligible after the appropriate assessment, and the device, trained clinician, supplies, time, and pain-management plan are available.
Do not require another visit solely because your usual workflow separates counseling from placement. Same-day placement can be appropriate. If a genuine preparation or safety need requires another visit, explain the reason and arrange a reliable next step.
CDC guidance on avoiding unnecessary contraceptive-access barriers; CDC intrauterine contraception practice recommendations.
Document and follow through
A procedure note should let another clinician understand what was done and how to care for the patient afterward. Use the actual procedure's documentation requirements. A practical starting checklist is indication and relevant findings, consent and alternatives, identity/site checks, technique and site, drugs or devices used, findings or specimen handling, complications, aftercare, and follow-up.
Record quantities and units accurately. “Steroid injected” is not enough to reconcile a drug claim. For a biopsy, specimen identity and destination matter. For a device, use the required device identifiers and procedure details. Keep any separately billed problem assessment recognizable in the record.
Following a biopsy result
You complete a biopsy and send the specimen. The patient receives wound-care instructions. Pathology is expected later.
Next tasks: track receipt of the pathology report, review it, communicate the interpretation, and arrange any indicated further care. Tell the patient when to expect contact and what to do if they hear nothing.
If the report does not arrive as expected, check specimen processing and report routing.
Result completion and accepted handoffs; ONC SAFER test-result guide.
A biopsy record another clinician can use
Fictional completed example. These findings and procedural details belong to this case; they are not default chart entries or a technique guide.
Reason and site: Persistent 12 mm scaly plaque on the left dorsal forearm despite treatment for dermatitis. Diagnostic question: inflammatory dermatitis versus squamous cell carcinoma in situ. Punch biopsy selected to obtain tissue for histology.
Discussion: Discussed biopsy, dermatology referral, bleeding, infection, scar, and possible need for further sampling or treatment. Patient elected biopsy and consented. Identity and marked site confirmed; medications and allergies reviewed.
Procedure: Site prepared with chlorhexidine. Local anesthesia with 1 mL of 1% lidocaine without epinephrine, total 10 mg. A 4 mm punch specimen was obtained and placed in formalin, labeled with patient identifiers and left dorsal forearm site, and sent to pathology. Hemostasis and closure with one interrupted 4-0 nylon suture. Patient tolerated the procedure; no immediate complication.
Aftercare: Petrolatum and dressing applied; written wound care reviewed. Patient will contact the office for persistent bleeding, increasing pain, spreading redness, drainage, or fever. Suture-removal visit arranged for day 10. I will review and communicate pathology; our results nurse will check for the report in one week and notify me if missing. Patient will call if no result discussion within two weeks.
Aftercare and timing reflect this case and the practice's pathology turnaround. Keep any separate problem assessment recognizable in its own part of the record.
AAD: biopsy wound care and reasons to contact the clinician.
Separate the procedure and E/M
Evaluation and management (E/M) is the clinical work of assessing a problem and making a management plan. The ordinary assessment needed to perform a minor procedure is included in its payment. Talking with the patient, checking the site, and obtaining consent do not automatically support an additional office E/M.
When you perform a significant, separately identifiable E/M beyond the procedure's usual work, it may be separately reportable with modifier 25. A different diagnosis is not mandatory, but the distinct work must be evident. An additional diagnosis on the claim is not proof that the work occurred.
Two versions of a knee-injection appointment
Version A: the patient arrives for an already planned injection. You confirm the usual procedural information, obtain consent, and perform it. Start with the procedure code. Do not automatically add an E/M.
Version B: you also assess hypertension and diabetes, both stable at their agreed goals, and make documented prescription-management decisions. That distinct work can support moderate medical decision-making (MDM) and an established-patient 99214-25, in addition to the qualifying procedure.
Two addressed stable chronic illnesses establish moderate problems; prescription management establishes moderate risk. These are two of the three MDM elements. The injection itself does not create the visit level.
Time and decision-making are different routes
A separate office E/M can be selected by MDM or qualifying same-day time from a physician or other qualified health care professional (QHP). Exclude separately billed procedure time when using time. If the separate E/M meets moderate MDM, it does not also need 30 minutes to support 99214. For a time-selected service, less qualifying E/M time may support a lower code. For an MDM-selected service, the complexity of the separate work determines the level.
The same applies on a prior day: discussing a procedure does not automatically establish a 99214. Code the service actually performed. Separating visits does not create a right to bill an otherwise unsupported E/M.
Learn MDM with worked examples; CMS E/M guidance; CMS global-surgery guidance.
Understand the global period
A global surgical package includes specified care around a procedure in one payment. Its global period determines the relevant time window. Routine related postoperative care may therefore be clinically necessary without being a separately payable office visit.
| CMS indicator | Meaning | Practical consequence |
|---|---|---|
000 | The surgical package includes relevant care on the procedure date; there are no included postoperative days. | Zero days does not mean an automatic same-day E/M. |
010 | Procedure day plus ten postoperative days | Routine related follow-up during that period is included. |
090 | One preoperative day, the procedure day, and ninety postoperative days | Major-surgery decision and follow-up rules need separate attention. |
XXX | The global-surgery concept does not apply. | Other bundling and E/M rules can still apply. |
Example: simple incision and drainage, 10060, has a ten-day global period in the cited CMS file. A routine related wound check in that period is included. An unrelated new problem is a different question and may support a separate service with the appropriate modifier and documentation.
Modifier 24 addresses an unrelated postoperative E/M. Modifier 57 addresses the initial decision for major surgery in the relevant preoperative window. Neither is a general substitute for modifier 25. When a return procedure or complication is involved, check its specific global-package rules rather than assuming every return is included or every return is separate.
CMS global-surgery booklet; CMS indicator definitions.
Tests, vaccines, drugs, and devices
Diagnostic tests are services with their own requirements
An electrocardiogram (ECG), spirometry, and vascular testing require a clinical indication and the appropriate performance and interpretation. Staff may perform authorized technical work; professional interpretation, supervision, and reporting follow the service's rules.
| Service | Key distinction |
|---|---|
ECG, 93000 | This code includes the tracing and interpretation/report. Confirm which components your practice actually furnishes. |
Limited arterial physiologic study, 93922 | A simple ankle-brachial index (ABI) does not necessarily meet the full study requirements. Diabetes alone does not guarantee payment for asymptomatic screening. |
Spirometry, 94010 | Perform and document the qualifying test for an appropriate indication. |
A diagnostic-test code without a surgical global period can still have same-day edits or documentation requirements. Check the actual code pair and modifier requirements.
Vascular-study coverage example; MAC clarification of simple ABI versus 93922. Local coverage applies in the stated jurisdiction.
Vaccines: identify the benefit before the claim
Vaccination may involve payment for the vaccine product and administration. Medicare Part B and Part D use different pathways. Influenza and pneumococcal vaccines are examples of Part B services; shingles and RSV vaccines are generally Part D. Your office needs a workable billing route for the particular product and plan.
For Medicare, G0008, G0009, and G0010 identify administration of influenza, pneumococcal, and hepatitis B vaccines respectively, subject to benefit rules. Do not assume the general administration code 90471 describes every Medicare vaccination claim.
A vaccine-only encounter does not also support 99211 under Medicare NCCI. A significant, separately identifiable problem E/M may be reportable with modifier 25. See the G2211 preventive-service exception for qualifying combinations.
Medicare Part D vaccine coverage; 2026 NCCI manual, Chapter XI; G2211 FAQ.
Drugs, devices, and routine supplies
Routine supplies integral to a procedure are generally included in its payment. A separately payable drug or device requires the right product code, units, documentation, and coverage. A code's existence alone does not establish separate payment.
For example, J3301 describes triamcinolone acetonide per 10 mg. If the documented administered dose were 40 mg, the drug quantity would correspond to four units—not forty. That is a units example, not a recommended dose. Select the actual product and apply the current billing rules.
For applicable separately payable Part B drugs from single-dose containers, check discarded-drug documentation and the JW or JZ requirements. JW identifies eligible discarded amounts; JZ indicates no discarded amount when required.
CMS discarded-drug resources; CMS claims-manual requirements.
Work through a complete visit
An established patient attends a planned, clinically appropriate knee injection. You also assess stable hypertension and diabetes and make documented decisions to continue their prescriptions. Total physician time is 42 minutes, including 18 minutes of separately reported procedural work.
During the visit, you discover that a positive FIT from last week has not led to colonoscopy. The patient saw the message but could not schedule at the referred facility because it is outside their plan's network. They thought that meant no further action was needed.
Choose the office E/M basis, decide whether modifier 25 and G2211 apply, and identify the unfinished follow-up. Then compare your decisions with the answer.
Work through the decisions
- Separate the work. The routine injection work belongs to the procedure. The distinct management of two stable chronic illnesses and their prescriptions supports moderate MDM and an established-patient
99214-25. Qualifying E/M time is 24 minutes, which alone would support 99213; it does not prevent selecting 99214 by MDM. - Check the add-on exception. An ongoing primary care relationship does not override G2211's modifier-25 restriction. An ordinary joint injection does not meet the designated preventive-service exception, so do not add G2211 to this combination.
- Restore the clinical plan. Explain that a positive FIT needs diagnostic colonoscopy, and that reading the message did not complete the evaluation. Confirm understanding and address the patient's concerns.
- Fix the actual access problem. Ask the team to identify an appropriate participating endoscopy service and verify the plan's requirements and patient costs. Changing the diagnosis to secure payment or repeating FIT does not resolve the network problem.
- Name the unfinished work. Assign an owner to confirm scheduling and completion, review the colonoscopy report, and communicate the next plan. Also give and document the injection's aftercare and contact instructions. The visit can end while these separately tracked tasks remain open.
Build and test a service
Start with a service your patients need and your team can deliver well. Document the indication and exclusion criteria, who performs each step, equipment and medication needs, specimen/result pathway, aftercare, urgent-contact process, coding, and cost assumptions. These are practice-design choices to make explicit.
Pilot the workflow and review actual procedure duration, total room time, cancellations, patient burden, complications, incomplete follow-up, denials, and collections after costs. A service that looks attractive in an RVU table may be a poor fit for the local workflow; a modestly paid service may meaningfully improve access.
The patient returns for a routine related wound check five days after 10060. Bill another office visit automatically?
No. The procedure has a ten-day global period, and routine related postoperative care is included. Assess any separate unrelated problem or unusual circumstance under the applicable rules rather than automatically billing or automatically dismissing it.
A patient comes only for Shingrix. Use the same Part B pathway as pneumococcal vaccine and add 99211?
No. Shingrix is generally a Part D vaccine and needs the appropriate benefit/claim pathway. Vaccine-only administration does not separately support 99211 under Medicare NCCI.
An eligible patient wants same-day contraception and your team is ready. Delay it to create a second visit?
No. A scheduling choice should reflect patient preference, clinical appropriateness, preparation, and capacity. Another appointment is appropriate when it solves a real care need; it does not automatically create a separately supported office service.
Read RVUs and compare costs
A work relative value unit (RVU) describes relative professional work. Practice expense reflects resources such as staff, space, equipment, and supplies. The malpractice component is separate. Total RVUs combine all three; the practice-expense component is not a direct statement of the cost of a tray or machine in your office.
The Medicare Physician Fee Schedule applies separate geographic adjustments to the components and then a conversion factor, with other applicable adjustments. A payer's allowed amount, actual collection, and an employee's production credit can therefore be different numbers.
| Service | Work RVUs | Total RVUs |
|---|---|---|
Established moderate office E/M, 99214 | 1.92 | 4.06 |
Major joint injection without ultrasound, 20610 | 0.77 | 2.06 |
First punch biopsy, 11104 | 0.81 | 3.63 |
If a qualifying 99214 and 20610 are separately reportable, their unadjusted RVU sums are 2.69 work and 6.12 total. That arithmetic is a reference, not a guarantee of collection or margin. Drugs, payer edits, costs, and compensation terms remain separate questions.
CMS RVU26B; CMS payment calculation overview.
Higher payment does not necessarily mean higher margin
Hypothetical example: service A collects $150 and incurs $65 in incremental supplies and staff costs. Service B collects $120 and incurs $20. Their contributions before remaining overhead are $85 and $100.
B leaves more after those costs despite a lower payment. To compare scheduling, also account for clinician time, room turnover, follow-up work, unused capacity, and patient access. Do not call this full profit without including the remaining costs.
For an employed physician, the corresponding question is how the contract credits the actual work. CMS does not guarantee that a particular employer will credit every reported RVU.
Evaluate the 2027 proposal
Proposed policy · not final as of September 4, 2026
CMS has proposed reducing payment when an office/outpatient E/M and a procedure with a 0-, 10-, or 90-day global period are furnished on the same day by the same physician or a physician in the same practice. Under the proposal, the highest-priced eligible service would be paid in full and the other eligible services at 50%.
Verify the final rule and implementation instructions before changing payment forecasts or scheduling policies.
Using the earlier 99214/20610 example purely to illustrate the proposed reduction, and assuming no geographic or other changes, 4.06 + half of 2.06 equals 5.09 total RVU-equivalent units. This isolates one proposal; it is not a forecast of a 2027 allowed amount.
Check the actual global indicator. A service called a “procedure” in ordinary language is not necessarily a 000/010/090 service. IUD insertion 58300, for example, has an XXX indicator in the cited 2026 file. Also distinguish the existing multiple-procedure payment rules from this proposed E/M policy.
CMS CY 2027 proposed-rule fact sheet; 2026 code indicators.
Procedure reference
Use this table after choosing the appropriate clinical service. These are selected first/base codes, not a complete coding guide. Technique, site, number of lesions, additional services, units, and payer rules can change the code.
Selected procedure codes and April 2026 RVUs
| Service | Code | Work | Total | Global |
|---|---|---|---|---|
| Simple incision and drainage | 10060 | 1.19 | 3.85 | 010 |
| First tangential skin biopsy | 11102 | 0.64 | 2.86 | 000 |
| First punch skin biopsy | 11104 | 0.81 | 3.63 | 000 |
| Skin tags, up to 15 | 11200 | 0.80 | 2.76 | 010 |
| First nail avulsion | 11730 | 1.02 | 3.34 | 000 |
| First premalignant lesion destruction | 17000 | 0.59 | 1.99 | 010 |
| Benign lesion destruction, up to 14 | 17110 | 0.68 | 3.33 | 010 |
| Tendon sheath/ligament injection | 20550 | 0.73 | 1.81 | 000 |
| Small joint/bursa injection without ultrasound | 20600 | 0.64 | 1.68 | 000 |
| Major joint/bursa injection without ultrasound | 20610 | 0.77 | 2.06 | 000 |
| Impacted cerumen removal with instrumentation | 69210 | 0.59 | 1.43 | 000 |
| Contraceptive implant insertion | 11981 | 1.11 | 3.22 | 000 |
| IUD insertion | 58300 | 0.98 | 3.16 | XXX |
| Chronic-migraine chemodenervation service | 64615 | 1.80 | 4.70 | 010 |
Coverage is separate from code selection. Cosmetic lesion removal, for example, is not made covered by choosing a valid destruction code. Drug/device payment is not included in the work/total comparison above merely because the procedure uses a product.
Selected diagnostic and vaccine-administration RVUs
| Code | Work | Total |
|---|---|---|
93000 | 0.17 | 0.46 |
93922 | 0.24 | 2.49 |
94010 | 0.17 | 0.89 |
90471 | 0.17 | 0.66 |
90472 | 0.15 | 0.48 |
These general CPT administration values do not substitute for Medicare's vaccine-specific administration payment rules.
Data source: CMS RVU26B, national non-facility non-QP file, updated May 1, 2026. QP refers to qualifying alternative-payment-model participant status; the corresponding conversion factor can differ. Current payment and coverage guidance should be checked before billing.